FDA's New COVID-19 Vaccine Approval Policies

FDA shifts COVID-19 vaccine approval policies to focus on high-risk individuals, will demand more robust data for low-risk individuals. US to move away from one-size-fits-all approach. Trust in scientific community has declined.